These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12439432)

  • 21. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
    Bolognese L
    Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet glycoprotein IIb/IIIa receptor inhibition in primary angioplasty for acute myocardial infarction: The new paradigm of direct revascularization.
    Albirini A; Brener SJ
    Int J Cardiovasc Intervent; 2001 Mar; 4(1):7-14. PubMed ID: 12431334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
    Patel VB; Moliterno DJ
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction.
    L'Allier PL; Lincoff AM
    J Thromb Thrombolysis; 2001 Feb; 11(1):83-91. PubMed ID: 11248791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoprotein IIb/IIIa receptor inhibitor-thrombolytic combination therapy for acute myocardial infarction.
    Maranian AM; Steinhubl SR
    Curr Cardiol Rep; 2002 Jul; 4(4):313-9. PubMed ID: 12052270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet glycoprotein IIb/IIIa integrin inhibition in acute myocardial infarction.
    O'Shea C; Tcheng JE
    J Invasive Cardiol; 1999 Aug; 11(8):494-9. PubMed ID: 10745582
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycoprotein IIb/IIIa combination therapy in acute myocardial infarction: tailoring therapies to optimize outcome.
    Vivekananthan DP; Moliterno DJ
    J Thromb Thrombolysis; 2002 Feb; 13(1):35-9. PubMed ID: 11994558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycoprotein IIb/IIIa receptor antagonists in the treatment of acute ST elevation MI: from hypotheses to unexpected recent observations.
    Ross AM
    J Thromb Thrombolysis; 2003 Apr; 15(2):85-9. PubMed ID: 14618074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASSENT-3: implications for future trial design and clinical practice.
    Van de Werf F
    Eur Heart J; 2002 Jun; 23(12):911-2. PubMed ID: 12069439
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycoprotein IIb/IIIa Inhibition as an adjunct to rescue angioplasty after failed fibrinolysis.
    Sallach JA; Greenbaum AB
    J Thromb Thrombolysis; 2001 Feb; 11(1):5-9. PubMed ID: 11248785
    [No Abstract]   [Full Text] [Related]  

  • 31. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.
    Topol EJ
    Circulation; 1998 Jan; 97(2):211-8. PubMed ID: 9445175
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacotherapy during percutaneous coronary intervention in acute myocardial infarction.
    Rognoni A
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):83. PubMed ID: 22963496
    [No Abstract]   [Full Text] [Related]  

  • 33. Antiplatelet Therapy in AMI: Combining GP IIb/IIIa Inhibition with Reduced-dose Fibrinolytic Therapy.
    Watkins SP; de Lemos JA
    Curr Interv Cardiol Rep; 2001 Aug; 3(3):235-243. PubMed ID: 11485693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanical thrombectomy to the RESCUE.
    Bass TA
    Catheter Cardiovasc Interv; 2002 Feb; 55(2):244. PubMed ID: 11835657
    [No Abstract]   [Full Text] [Related]  

  • 35. 22nd congress of the European Society of Cardiology, Amsterdam.
    Wroe CD
    Int J Clin Pract; 2000 Sep; 54(7):459-60. PubMed ID: 11202979
    [No Abstract]   [Full Text] [Related]  

  • 36. Reteplase plus abciximab and reteplase alone led to similar 30-day mortality rates in acute MI.
    Borzak S
    ACP J Club; 2002; 136(2):42-3. PubMed ID: 11874267
    [No Abstract]   [Full Text] [Related]  

  • 37. Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.
    Lincoff AM
    Rev Cardiovasc Med; 2002; 3 Suppl 1():S13-9. PubMed ID: 12439432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Vandoni P; Poli A; Fetiveau R; Cafiero F; D'Urbano M; De Servi S
    Ital Heart J Suppl; 2002 May; 3(5):539-43. PubMed ID: 12064193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
    Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
    Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.